Abstract
Hematopoietic stem cell (HSC) transplantation is a curative treatment for hematologic malignancies and innate immunodeficiency, but its applications are limited to matched donors, and the availability of umbilical cord blood of immune types. Therefore, derivation of HSCs from patient-specific human induced pluripotent stem cells (hiPSCs) is a holy grail in regenerative medicine. However, derivation of HSCs from iPSCs has proven elusive. Here, the authors developed a method to derive hematopoietic stem and progenitor cells (HSPCs) by combining two established methods. The first method mimics embryonic development by directed differentiation of iPSCs into a cellular state termed hemogenic endothelium (HE) by stepwise exposure to different combinations of morphogens and cytokines. In the second method, transcription factors are induced in HE cells for specification into HSCs. By combining these approaches, the authors identified a set of select transcription factors that programmed HE cells into HSPCs with long-term and multilineage capacity in vivo. In this chapter, I provide an overview of this technology, technical tips, and future applications.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Kennedy M et al (2012) T lymphocyte potential marks the emergence of definitive hematopoietic progenitors in human pluripotent stem cell differentiation cultures. Cell Rep 2:1722–1735. https://doi.org/10.1016/j.celrep.2012.11.003
Pereira CF et al (2013) Induction of a hemogenic program in mouse fibroblasts. Cell Stem Cell 13:205–218. https://doi.org/10.1016/j.stem.2013.05.024
Riddell J et al (2014) Reprogramming committed murine blood cells to induced hematopoietic stem cells with defined factors. Cell 157:549–564. https://doi.org/10.1016/j.cell.2014.04.006
Ditadi A et al (2015) Human definitive haemogenic endothelium and arterial vascular endothelium represent distinct lineages. Nat Cell Biol 17:580–591. https://doi.org/10.1038/ncb3161
Ditadi A, Sturgeon CM (2016) Directed differentiation of definitive hemogenic endothelium and hematopoietic progenitors from human pluripotent stem cells. Methods 101:65–72. https://doi.org/10.1016/j.ymeth.2015.10.001
Suzuki N et al (2013) Generation of engraftable hematopoietic stem cells from induced pluripotent stem cells by way of teratoma formation. Mol Ther 21:1424–1431. https://doi.org/10.1038/mt.2013.71
Amabile G et al (2013) In vivo generation of transplantable human hematopoietic cells from induced pluripotent stem cells. Blood 121:1255–1264. https://doi.org/10.1182/blood-2012-06-434407
Sandler VM et al (2014) Reprogramming human endothelial cells to haematopoietic cells requires vascular induction. Nature 511:312–318. https://doi.org/10.1038/nature13547
Lis R et al (2017) Conversion of adult endothelium to immunocompetent haematopoietic stem cells. Nature 545:439–445. https://doi.org/10.1038/nature22326
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2019 Springer Science+Business Media, LLC, part of Springer Nature
About this protocol
Cite this protocol
Sugimura, R. (2019). Derivation of Hematopoietic Stem and Progenitor Cells from Human Pluripotent Stem Cells. In: Hyun, I., De Los Angeles, A. (eds) Chimera Research . Methods in Molecular Biology, vol 2005. Humana, New York, NY. https://doi.org/10.1007/978-1-4939-9524-0_3
Download citation
DOI: https://doi.org/10.1007/978-1-4939-9524-0_3
Published:
Publisher Name: Humana, New York, NY
Print ISBN: 978-1-4939-9523-3
Online ISBN: 978-1-4939-9524-0
eBook Packages: Springer Protocols